These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4832585)

  • 41. Evaluation of allopurinol use in patients with gout.
    Zell SC; Carmichael JM
    Am J Hosp Pharm; 1989 Sep; 46(9):1813-6. PubMed ID: 2801716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
    Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK
    Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.
    Fairbanks LD; Cameron JS; Venkat-Raman G; Rigden SP; Rees L; Van'T Hoff W; Mansell M; Pattison J; Goldsmith DJ; Simmonds HA
    QJM; 2002 Sep; 95(9):597-607. PubMed ID: 12205338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A; MacDonald PA; Chefo S; Gunawardhana L
    Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension, renal function and gout.
    Gibson T; Highton J; Simmonds HA; Potter CF
    Postgrad Med J; 1979; 55 Suppl 3():21-5. PubMed ID: 504036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Regression of gout tophi under long-term therapy with allopurinol].
    Kröpelin T; Mertz DP
    Med Klin; 1972 Apr; 67(17):614-8. PubMed ID: 4624843
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of azelnidipine on uric acid metabolism in patients with essential hypertension.
    Miyazaki S; Hamada T; Hirata S; Ohtahara A; Mizuta E; Yamamoto Y; Kuwabara M; Nosaka Y; Igawa O; Ogino K; Kato M; Yoshida A; Ninomiya H; Cheng J; Moriwaki Y; Yamamoto K; Hisatome I
    Clin Exp Hypertens; 2014; 36(7):447-53. PubMed ID: 24433018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
    [No Abstract]   [Full Text] [Related]  

  • 51. Concentration and synthesis of phosphoribosylpyrophosphate in erythrocytes from normal, hyperuricemic, and gouty subjects.
    Meyskens FL; Williams HE
    Metabolism; 1971 Aug; 20(8):731-42. PubMed ID: 4327978
    [No Abstract]   [Full Text] [Related]  

  • 52. [Allopurinol treatment of malignant uric acid lithiasis in a gouty patient with massive hyperuricosuria].
    de Vries A; Frank M; Sperling O
    J Urol Nephrol (Paris); 1968; 74(4):403-8. PubMed ID: 5675122
    [No Abstract]   [Full Text] [Related]  

  • 53. Gout.
    Roddy E; Mallen CD; Doherty M
    BMJ; 2013 Oct; 347():f5648. PubMed ID: 24473446
    [No Abstract]   [Full Text] [Related]  

  • 54. Uric acid renal lithiasis: management by allopurinol.
    Godfrey RG; Rankin TJ
    J Urol; 1969 May; 101(5):643-7. PubMed ID: 5780597
    [No Abstract]   [Full Text] [Related]  

  • 55. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
    Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
    Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum and urine uric acid content in hemoblastoses and gout as well as its modification by allopurinol].
    Helbig W; Findeisen B
    Z Gesamte Inn Med; 1971 Apr; 26(7):233-7. PubMed ID: 5285596
    [No Abstract]   [Full Text] [Related]  

  • 57. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
    Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA
    Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allopurinol therapy of gout with renal complications.
    Sjöberg KH
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):688-90. PubMed ID: 5958699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.